ChartRow logo
ELAN
Elanco Animal Health IncorporatedStock · Health Care
$22.51+$0.38 (+1.72%)as of market close, Aug 13, 2026
☾ After hours:$22.51+0.00%3:59 PM ET
CompareLLYUNHJNJABBVISRGTMO

ELAN financial statements

The full income statement, balance sheet, and cash-flow statement for Elanco Animal Health Incorporated (ELAN), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 494.3M2024-09 494.4M2024-12 494.6M2025-03 496.6M2025-06 496.8M2025-09 496.9M2025-12 497.2M2026-03 499.4M2026-06 499.6M+1.1% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

As-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue
4.71B
YoY+6.2%
4.44B
YoY+0.5%
4.42B
YoY+0.1%
4.41B
YoY-7.4%
4.76B
YoY+45.6%
2.59B
YoY+6.4%
2.44B
YoY-2.0%
2.49B
Research & development
368M
YoY+7.0%
344M
YoY+5.2%
327M
YoY+1.9%
321M
YoY-13.0%
369M
YoY+12.2%
Selling, general & administrative
1.43B
YoY+8.8%
1.31B
YoY+2.3%
1.28B
YoY+1.6%
1.26B
YoY-9.8%
1.40B
YoY+40.7%
Restructuring
156M
YoY+254.5%
44.0M
0.00
YoY+100.0%
-7.00M
YoY-106.4%
110M
YoY-29.9%
Amortization of intangibles
543M
YoY+3.0%
527M
YoY-3.8%
548M
YoY+3.8%
528M
YoY-5.0%
556M
YoY+54.4%
Interest expense
277M
YoY+14.9%
241M
YoY+2.1%
236M
YoY+57.3%
Interest & investment income
43.0M
YoY+38.7%
31.0M
YoY+675.0%
4.00M
Other non-operating income
-75.0M
YoY-134.4%
-32.0M
YoY-540.0%
-5.00M
YoY-102.8%
Pre-tax income
-224M
YoY-145.9%
488M
YoY+140.8%
-1.20B
YoY-1559.7%
-72.0M
YoY+87.4%
-571M
YoY+15.7%
Income tax
8.00M
YoY-94.7%
150M
YoY+316.7%
36.0M
YoY+500.0%
6.00M
YoY+106.8%
-88.0M
YoY+14.6%
Net income
-232M
YoY-168.6%
338M
YoY+127.5%
-1.23B
YoY-1478.2%
-78.0M
YoY+83.9%
-483M
YoY+15.9%
-$0.47
YoY-169.1%
$0.68
YoY+127.2%
-$2.50
YoY-1462.5%
-$0.16
YoY+83.8%
-$0.99
YoY+23.8%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
3.46B
YoY+7.6%
3.21B
YoY-5.6%
3.41B
YoY+3.9%
3.28B
YoY+0.2%
3.27B
YoY-4.2%
13.4B
YoY+5.9%
12.6B
YoY-12.2%
14.4B
YoY-7.3%
15.5B
YoY-6.0%
16.5B
YoY-6.9%
1.60B
YoY+21.4%
1.31B
YoY+6.0%
1.24B
YoY-27.1%
1.70B
YoY+3.3%
1.65B
YoY-20.7%
6.81B
YoY+4.5%
6.52B
YoY-19.9%
8.14B
YoY-0.8%
8.20B
YoY-8.6%
8.97B
YoY-2.7%
6.55B
YoY+7.4%
6.10B
YoY-2.0%
6.22B
YoY-14.6%
7.29B
YoY-2.9%
7.51B
YoY-11.2%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
560M
YoY+3.5%
541M
YoY+99.6%
271M
YoY-40.0%
452M
YoY-6.4%
483M
YoY+1278.0%
-279M
YoY-124.1%
1.16B
YoY+785.2%
-169M
YoY+5.6%
-179M
YoY+66.2%
-530M
YoY+88.9%
-275M
YoY+81.6%
-1.49B
YoY-1697.6%
-83.0M
YoY+84.9%
-549M
YoY-361.4%
210M
YoY-95.8%
FX effect on cash
71.0M
YoY+178.0%
-91.0M
YoY-658.3%
-12.0M
YoY+29.4%
-17.0M
YoY+45.2%
-31.0M
YoY-214.8%
Net change in cash
77.0M
YoY-33.6%
116M
YoY+1557.1%
7.00M
YoY+102.4%
-293M
YoY-322.0%
132M
YoY-18.0%
Interest paid
206M
YoY-30.4%
296M
YoY-21.9%
379M
YoY+42.5%
266M
YoY+20.4%
221M
YoY+68.7%
Income taxes paid
225M
YoY+60.7%
140M
YoY+47.4%
95.0M
YoY+2.2%
93.0M
YoY-38.4%
151M
YoY+55.7%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap
11.3B
YoY+87.8%
5.99B
YoY-18.4%
7.34B
YoY+26.7%
5.79B
YoY-56.8%
13.4B
YoY-7.3%
P/E
17.7×
P/S
2.4×
YoY+76.8%
1.3×
YoY-19.7%
1.7×
YoY+31.7%
1.3×
YoY-54.7%
2.8×
YoY-36.3%
P/B
1.7×
YoY+74.9%
1.0×
YoY-17.9%
1.2×
YoY+38.7%
0.9×
YoY-51.7%
1.8×
YoY+4.5%
P/FCF
39.6×
YoY+160.6%
15.2×
11.8×
YoY-71.6%
41.4×
5.6%
2.5%
YoY-61.6%
6.6%
8.5%
YoY+251.9%
2.4%
Source filing10-K10-K10-K10-K10-K

About this data

Source: ELAN's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all ELAN filings on SEC EDGAR → Not investment advice.